These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. ALDH1 might influence the metastatic capability of HeLa cells. Yao T; Lu R; Li Y; Peng Y; Ding M; Xie X; Lin Z Tumour Biol; 2015 Sep; 36(9):7045-51. PubMed ID: 25864109 [TBL] [Abstract][Full Text] [Related]
4. Gene expression profiles of prostate cancer stem cells isolated by aldehyde dehydrogenase activity assay. Nishida S; Hirohashi Y; Torigoe T; Kitamura H; Takahashi A; Masumori N; Tsukamoto T; Sato N J Urol; 2012 Jul; 188(1):294-9. PubMed ID: 22608744 [TBL] [Abstract][Full Text] [Related]
5. High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling. Kim D; Choi BH; Ryoo IG; Kwak MK Cell Death Dis; 2018 Aug; 9(9):896. PubMed ID: 30166520 [TBL] [Abstract][Full Text] [Related]
6. Upregulation of FoxM1 by MnSOD Overexpression Contributes to Cancer Stem-Like Cell Characteristics in the Lung Cancer H460 Cell Line. Fu Z; Cao X; Yang Y; Song Z; Zhang J; Wang Z Technol Cancer Res Treat; 2018 Jan; 17():1533033818789635. PubMed ID: 30111255 [TBL] [Abstract][Full Text] [Related]
7. Coordinated expression of REG4 and aldehyde dehydrogenase 1 regulating tumourigenic capacity of diffuse-type gastric carcinoma-initiating cells is inhibited by TGF-β. Katsuno Y; Ehata S; Yashiro M; Yanagihara K; Hirakawa K; Miyazono K J Pathol; 2012 Nov; 228(3):391-404. PubMed ID: 22430847 [TBL] [Abstract][Full Text] [Related]
8. Down-regulation of FoxM1 by thiostrepton or small interfering RNA inhibits proliferation, transformation ability and angiogenesis, and induces apoptosis of nasopharyngeal carcinoma cells. Jiang L; Wang P; Chen L; Chen H Int J Clin Exp Pathol; 2014; 7(9):5450-60. PubMed ID: 25337187 [TBL] [Abstract][Full Text] [Related]
9. Aldh1 Expression and Activity Increase During Tumor Evolution in Sarcoma Cancer Stem Cell Populations. Martinez-Cruzado L; Tornin J; Santos L; Rodriguez A; García-Castro J; Morís F; Rodriguez R Sci Rep; 2016 Jun; 6():27878. PubMed ID: 27292183 [TBL] [Abstract][Full Text] [Related]
10. Knockdown of Bmi1 inhibits the stemness properties and tumorigenicity of human bladder cancer stem cell-like side population cells. Zhu D; Wan X; Huang H; Chen X; Liang W; Zhao F; Lin T; Han J; Xie W Oncol Rep; 2014 Feb; 31(2):727-36. PubMed ID: 24337040 [TBL] [Abstract][Full Text] [Related]
11. Forkhead Box Q1 Is a Novel Target of Breast Cancer Stem Cell Inhibition by Diallyl Trisulfide. Kim SH; Kaschula CH; Priedigkeit N; Lee AV; Singh SV J Biol Chem; 2016 Jun; 291(26):13495-508. PubMed ID: 27129776 [TBL] [Abstract][Full Text] [Related]
12. Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway. An H; Kim JY; Lee N; Cho Y; Oh E; Seo JH Biochem Biophys Res Commun; 2015 Oct; 466(4):696-703. PubMed ID: 26407842 [TBL] [Abstract][Full Text] [Related]
13. 7-Difluoromethoxyl-5,4'-di-n-octyl genistein inhibits the stem-like characteristics of gastric cancer stem-like cells and reverses the phenotype of epithelial-mesenchymal transition in gastric cancer cells. Cao X; Ren K; Song Z; Li D; Quan M; Zheng Y; Cao J; Zeng W; Zou H Oncol Rep; 2016 Aug; 36(2):1157-65. PubMed ID: 27279287 [TBL] [Abstract][Full Text] [Related]
14. Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma. Yue L; Huang ZM; Fong S; Leong S; Jakowatz JG; Charruyer-Reinwald A; Wei M; Ghadially R Melanoma Res; 2015 Apr; 25(2):138-48. PubMed ID: 25643237 [TBL] [Abstract][Full Text] [Related]
15. Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells. Zhang X; Cheng L; Minn K; Madan R; Godwin AK; Shridhar V; Chien J Oncotarget; 2014 Nov; 5(22):11365-80. PubMed ID: 25426548 [TBL] [Abstract][Full Text] [Related]
16. Thiostrepton selectively targets breast cancer cells through inhibition of forkhead box M1 expression. Kwok JM; Myatt SS; Marson CM; Coombes RC; Constantinidou D; Lam EW Mol Cancer Ther; 2008 Jul; 7(7):2022-32. PubMed ID: 18645012 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of FOXM1 by thiostrepton sensitizes medulloblastoma to the effects of chemotherapy. Lin J; Zheng Y; Chen K; Huang Z; Wu X; Zhang N Oncol Rep; 2013 Oct; 30(4):1739-44. PubMed ID: 23912794 [TBL] [Abstract][Full Text] [Related]
18. Ovarian cancer stem cells express ROR1, which can be targeted for anti-cancer-stem-cell therapy. Zhang S; Cui B; Lai H; Liu G; Ghia EM; Widhopf GF; Zhang Z; Wu CC; Chen L; Wu R; Schwab R; Carson DA; Kipps TJ Proc Natl Acad Sci U S A; 2014 Dec; 111(48):17266-71. PubMed ID: 25411317 [TBL] [Abstract][Full Text] [Related]
19. FOXM1 is a downstream target of LPA and YAP oncogenic signaling pathways in high grade serous ovarian cancer. Fan Q; Cai Q; Xu Y Oncotarget; 2015 Sep; 6(29):27688-99. PubMed ID: 26299613 [TBL] [Abstract][Full Text] [Related]
20. Fibroblasts induce expression of FGF4 in ovarian cancer stem-like cells/cancer-initiating cells and upregulate their tumor initiation capacity. Yasuda K; Torigoe T; Mariya T; Asano T; Kuroda T; Matsuzaki J; Ikeda K; Yamauchi M; Emori M; Asanuma H; Hasegawa T; Saito T; Hirohashi Y; Sato N Lab Invest; 2014 Dec; 94(12):1355-69. PubMed ID: 25329002 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]